Avid Bioservices Inc CDMO

NAS: CDMO | ISIN: US05368M1062   14/11/2024
11,93 USD (-2,21%)
(-2,21%)   14/11/2024

2 december 2023 · Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 · Persbericht

16 juni 2022 · Avid Bioservices, Inc. and CRB highlight efforts that enabled opening of first phase of new viral vector facility in California in only eight months · Persbericht

26 oktober 2021 · Avid Bioservices Set to Join S&P SmallCap 600 · Persbericht

17 maart 2021 · Avid Bioservices to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum · Persbericht

10 maart 2021 · Avid Bioservices, Inc. Announces Pricing of $125 Million Offering of Exchangeable Senior Notes · Persbericht

8 maart 2021 · Avid Bioservices, Inc. Announces Proposed $125 Million Offering of Exchangeable Senior Notes · Persbericht

8 maart 2021 · Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2021 and Recent Developments · Persbericht

3 maart 2021 · Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock · Persbericht

1 maart 2021 · Avid Bioservices to Report Financial Results for Third Quarter of Fiscal Year 2021 After Market Close on March 8, 2021 · Persbericht

22 februari 2021 · Avid Bioservices Begins Phase 2 of its Myford Manufacturing Capacity Expansion Plan · Persbericht

3 februari 2021 · Humanigen and Avid Bioservices Enter into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing · Persbericht

Mijn selecties